..
According to Brazil’s Butantan biomedical center, the COVID-19 vaccine developed by China’s Sinovac Biotech has been found to be just 50.4 percent effective in Brazilian clinical trials. The number is significantly lower than the efficacy levels previously reported. However, Sinovac CEO Yin Weidong says the reports of lower efficacy rate are misleading.
..
Two senior managers from one of China’s top vaccine companies have resigned
PUBLISHED FRI, JAN 15 20212:57 AM EST
- Sinopharm, a state-owned giant in China’s coronavirus vaccine development, announced its chairman left the board Tuesday.
- The company cited personal reasons for Li Zhiming’s resignation, according to a filing for the Hong Kong-listed company.
- Li Hui, a director and audit committee member of Sinopharm subsidiary China National Medicines Corp. also resigned Tuesday due to personal reasons, a separate filing disclosed.
..
..
..
..
..
